H.B. Fuller: the self-help quarter the tape won't pay for
Margin expansion and a rejected BAS bid land while the shares sit 42% off their high — price/cost is working, the balance sheet is the debate.
FUL · Earnings Call · 2026-09-24
A self-help quarter the tape refuses to price
On the numbers, H.B. Fuller's fiscal Q3 was exactly the print management has been promising for two years. Revenue rose 5.2%, organic growth of 4.4% came entirely from “pricing actions are offsetting higher raw material costs and our restructuring efforts continue to enhance operating leverage” — Celeste Mastin, President and Chief Executive Officer · 2026-09-24, and adjusted EBITDA of $187 million lifted the margin 80 basis points to 19.9% with EPS up 21%. Gross margin reached 33.6%, up 1.8 points year over year, even though volume was down roughly 3%. None of this was volume-led. The tape disagrees. The shares have fallen 15.8% in 90 days, sit 22.9% below their June high and 42% below the 2024 peak — a $3.2B small-cap in a deep drawdown while beating. What the equity is discounting is leverage: effective net cash sits at -$2.0 billion, though interest coverage of 3.3x has improved year over year and net debt/EBITDA ticked down to just under 3x from 3.3x.What actually changed
The genuinely new items are three. First, the board rejected an unsolicited proposal for its BAS (Building Adhesive Solutions) unit. The keyword dissynergies is brand new to this company's vocabulary, and CFO John Corkrean explained why the unit is hard to carve out: “On the sourcing side, BAS is roughly 20% of H.B. Fuller's revenue. They probably represent about 35% to 40% of the solvents we buy. So they would -- that would have a significant impact from our purchasing power.” — John Corkrean, Executive Vice President and Chief Financial Officer · 2026-09-24 Yet CEO Celeste Mastin left the door open — “we think that we're the best owner of BAS. But we're always open-minded and willing to consider other alternatives that make sense.” — Celeste Mastin, President and Chief Executive Officer · 2026-09-24 The prior-quarter keyword best owner was already in the vocabulary; now it is tied to shareholder pressure and an explicit deleveraging logic: “the possibility that we will divest something is something we're taking very seriously because we know it would accelerate reducing our leverage.” — Celeste Mastin, President and Chief Executive Officer · 2026-09-24 Second, chip shortage is a new keyword. Electronics, one of the company's strongest engines, cooled as shortages weighed on mobile-phone production in Asia Pacific — a reversal from the first half. That is an industry condition, not a company excuse; the phrase also surfaced in the broader market's early-2025 keyword set. Third, the solar overhang has finally washed out. solar business now registers as a top decliner in the company's keyword momentum — a multi-quarter drag turned lapped comp. Meanwhile the recurring themes — the Quantum Leap restructuring, the AMS team acquisition, and broad End markets — carry forward, but with more specificity. Quantum Leap now carries a facility count (82 plants at end-2024 to ~62 exiting 2026, below 60 by 2027, toward a 55 goal) and a savings schedule: about $25 million realized through 2026, another $20-25 million in 2027, en route to $75 million of annualized conversion savings by 2030.Riding the wave — or on its own island?
The market's loudest current theme is the Tariff refund, which topped the global keyword board and shows up in the fresh reports of CBRL, COST, MLKN and KMD.NZ. H.B. Fuller barely touches it. Its inflation story is a different animal — petrochemical supply-chain dislocation, which Mastin calls a defining feature of the operating environment. That is a real contrast: this company is levered to raw-material cost rather than tariff mechanics, and it priced for it early. The prior-quarter framing was a market reset that management argued would be durable — “we believe this market reset is a very sustainable place for us to be” — Celeste Mastin, President and Chief Executive Officer · 2026-03-26 — and the current call simply says raw materials have stabilized at elevated levels.What to watch into 2027
Guidance is unchanged (organic up low single digits, EBITDA $655-670M, EPS $4.70-4.85), but the shape of next year is the story. “we will have carryover pricing, but we'll have carryover raw material impact as well... we would expect that we would have a positive gap between pricing and raws next year, but not as significant as this year.” — John Corkrean, Executive Vice President and Chief Financial Officer · 2026-09-24 Quantum Leap adds $20-25M, offsetting roughly $25M of normal inflation, and AMS should close by year-end — adding an 8%-growth medical business that would make Fuller the second-largest surgical tissue-bonding player in the world. The swing factor is demand. Management has repeatedly refused to lean on the macro — “We're expecting no macro help” — Celeste Mastin, President and Chief Executive Officer · 2026-01-15 — and this quarter it flagged the volatility directly:Mastin named China as the region to watch for 2027 and Europe as "looking up." The company's own base case has volume down low single digits this year. Until volume turns, the story is a balance-sheet repair job — and the market is treating it like one, at 26.5x price to free cash flow.We're seeing instances where customers are -- especially mid- and small-sized customers are en masse doubling the amount of time or the interval between their orders. And then sometimes they shrink rapidly, particularly when the headlines are out that the price of oil has dramatically increased.